qRT‐PCR analysis of SPRY4‐IT1 mRNA levels in glioma cell lines and NHA showed that high expression values of SPRY4‐IT1 were evident in most glioma cell lines (U87, U251, SNB19, and LN229) compared with NHA (Figure 2A). The gene discussed is SPRY4; the disease is central nervous system cancer.